Results 231 to 240 of about 4,445,450 (251)

Efficacy of B-Cell–Targeted Therapy with Rituximab in Patients with Rheumatoid Arthritis

New England Journal of Medicine, 2004
Paul Emery, Jonathan Edwards, Tim Shaw
exaly  

Treatment of Rheumatoid Arthritis with a Recombinant Human Tumor Necrosis Factor Receptor (p75)–Fc Fusion Protein

New England Journal of Medicine, 1997
Roy Fleischmann, Larry Moreland, Michael H Schiff   +2 more
exaly  

Association of the B-Cell Alloantigen DRw4 with Rheumatoid Arthritis

New England Journal of Medicine, 1978
Peter Stastny, Peter Stastny
exaly  

RHEUMATOID FACTORS AND THE ETIOLOGY OF RHEUMATOID ARTHRITIS^*

Annals of the New York Academy of Sciences, 1965
H H, Fudenberg, E C, Franklin
openaire   +2 more sources

Cytokine Pathways and Joint Inflammation in Rheumatoid Arthritis

New England Journal of Medicine, 2001
Ernest Choy, Gabriel S Panayi, G S Panayi   +2 more
exaly  

STAT4 and the Risk of Rheumatoid Arthritis and Systemic Lupus Erythematosus

New England Journal of Medicine, 2007
Daniel L. Kastner, Paul I W de Bakker, Lars Klareskog   +2 more
exaly  

Rheumatoid Factor ‐ Autospecificity or Isospecificity?

Vox Sanguinis, 1965
K, AHO, M, HARBOE, K, SIEVERS
openaire   +2 more sources

Rheumatoid Arthritis — Pathophysiology and Implications for Therapy

New England Journal of Medicine, 1990
Franklin H Epstein, E D Harris, Edward D Harris   +2 more
exaly  

Placebo-Controlled Trial of Tofacitinib Monotherapy in Rheumatoid Arthritis

New England Journal of Medicine, 2012
Joel M Kremer, Hendrik Schulze-Koops, Gene Wallenstein   +2 more
exaly  

Baricitinib versus Placebo or Adalimumab in Rheumatoid Arthritis

New England Journal of Medicine, 2017
Michael E Weinblatt, Edward Keystone, Sergey Yakushin   +2 more
exaly